Found: 17
Select item for more details and to access through your institution.
Pneumococcal vaccination during chemotherapy in children treated for acute lymphoblastic leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Antithrombin and fibrinogen levels as predictors for plasma L-asparaginase activity in children with acute lymphoblastic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
2699. Pneumococcal Vaccination During Chemotherapy in Children Treated for Acute Lymphoblastic Leukemia.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S949, doi. 10.1093/ofid/ofz360.2376
- By:
- Publication type:
- Article
The timing of cyclic cytotoxic chemotherapy can worsen neutropenia and neutrophilia.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 2, p. 687, doi. 10.1111/bcp.14424
- By:
- Publication type:
- Article
Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 4, p. e192906, doi. 10.1001/jamanetworkopen.2019.2906
- By:
- Publication type:
- Article
Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0160310
- By:
- Publication type:
- Article
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 8, p. 1, doi. 10.1002/pbc.29581
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 3, p. 1, doi. 10.1002/pbc.29189
- By:
- Publication type:
- Article
Comment on: Acute lymphoblastic leukemia onset in a 3‐year‐old child with COVID‐19.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 3, p. 1, doi. 10.1002/pbc.28727
- By:
- Publication type:
- Article
Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 1, p. 1, doi. 10.1002/pbc.28719
- By:
- Publication type:
- Article
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001.
- Published in:
- Pediatric Blood & Cancer, 2018, v. 65, n. 3, p. 1, doi. 10.1002/pbc.26871
- By:
- Publication type:
- Article
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.
- Published in:
- 2017
- By:
- Publication type:
- journal article
L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 8, p. 1381, doi. 10.1002/pbc.25515
- By:
- Publication type:
- Article
Amplifications of DNA primase 1 ( PRIM1) in human osteosarcoma.
- Published in:
- Genes, Chromosomes & Cancer, 1999, v. 26, n. 1, p. 62, doi. 10.1002/(SICI)1098-2264(199909)26:1<62::AID-GCC9>3.0.CO;2-F
- By:
- Publication type:
- Article